• 1
    Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 17: 28932917
  • 2
    Chia V, Quraishi S, Devesa S et al. International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 2010; 19: 11511159
  • 3
    Chung P, Mayhew LA, Warde P, Winquist E, Lukka H. Management of stage I seminomatous testicular cancer: a systematic review. Clin Oncol (R Coll Radiol) 2010; 22: 616
  • 4
    Travis LB, Curtis RE, Storm H et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer.[see comment]. J Natl Cancer Inst 1997; 89: 14291439
  • 5
    Daugaard G, Petersen PM, Rorth M. Surveillance in stage I testicular cancer. Apmis. 2003; 111: 7683; discussion 5
  • 6
    Warde P, Gospodarowicz MK, Panzarella T et al. Stage I testicular seminoma: results of adjuvant irradiation and surveillance. J Clin Oncol 1995 13: 22552262
  • 7
    Warde PR, Gospodarowicz MK, Goodman PJ et al. Results of a policy of surveillance in stage I testicular seminoma. Int J Radiat Oncol Biol Phys 1993; 27: 1115
  • 8
    Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008; 53: 478496
  • 9
    Motzer RJ, Agarwal N, Beard C et al. NCCN clinical practice guidelines in oncology: testicular cancer. J Natl Compr Canc Netw 2009; 7: 672693
  • 10
    Wood L, Kollmannsberger C, Jewett M et al. Canadian consensus guidelines for the management of testicular germ cell cancer. Can Urol Assoc J. 2010; 4: e1938
  • 11
    Cummins S, Yau T, Huddart R, Dearnaley D, Horwich A. Surveillance in stage I seminoma patients: a long-term assessment. Eur Urol 2010; 57: 673678
  • 12
    Oliver RT. Limitations to the use of surveillance as an option in the management of stage I seminoma. Int J Androl 1987; 10: 263268
  • 13
    Oliver RT, Edmonds PM, Ong JY et al. Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys 1994; 29: 38
  • 14
    Tolan S, Vesprini D, Jewett MA et al. No role for routine chest radiography in stage I seminoma surveillance. Eur Urol 2010; 57: 474479
  • 15
    Vesprini D, Chung P, Tolan S et al. Utility of serum tumor markers during surveillance for stage I seminoma. Cancer [Evaluation Studies]. 2012; 118: 52455250
  • 16
    Horwich A, Alsanjari N, A'Hern R et al. Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer 1992; 65: 775778
  • 17
    von der Maase H, Specht L, Jacobsen GK et al. Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer 1993; 29A: 19311934
  • 18
    Fossa SD, Horwich A, Russell JM et al. Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol 1999; 17: 11461154
  • 19
    Germa-Lluch JR, Garcia del Muro X, Maroto P et al. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol 2002; 42: 553562; discussion 62-3
  • 20
    Ramakrishnan S, Champion AE, Dorreen MS, Fox M. Stage I seminoma of the testis: is post-orchidectomy surveillance a safe alternative to routine postoperative radiotherapy? Clin Oncol (R Coll Radiol) 1992; 4: 284286
  • 21
    Hoffman KE, Chen MH, Punglia RS, Beard CJ, D'Amico AV. Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma. J Clin Oncol 2008; 26: 39373942
  • 22
    Nattinger AB, Hoffman RG, Shapiro R, Gottlieb MS, Goodwin JS. The effect of legislative requirements on the use of breast-conserving surgery. N Engl J Med 1996; 335: 10351040
  • 23
    Oliver RT, Mead GM, Rustin GJ et al. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). J Clin Oncol 2011; 29: 957962
  • 24
    Tandstad T, Smaaland R, Solberg A et al. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group. J Clin Oncol 2011; 29: 719725
  • 25
    Chung PW, Warde PR, Panzarella T et al. Appropriate radiation volume for stage IIA/B testicular seminoma. Int J Radiat Oncol Biol Phys 2003; 56: 746748
  • 26
    Classen J, Schmidberger H, Meisner C et al. Radiotherapy for stages IIA/B testicular seminoma: final report of a prospective multicenter clinical trial. J Clin Oncol 2003; 21: 11011106
  • 27
    Vallis KA, Howard GC, Duncan W, Cornbleet MA, Kerr GR. Radiotherapy for stages I and II testicular seminoma: results and morbidity in 238 patients. Br J Radiol 1995; 68: 400405
  • 28
    Zagars GK, Pollack A. Radiotherapy for stage II testicular seminoma. Int J Radiat Oncol Biol Phys 2001; 51: 643649
  • 29
    Ng AK, Bernardo MV, Weller E et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002; 100: 19891996
  • 30
    Travis LB, Fossa SD, Schonfeld SJ et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005; 97: 13541365
  • 31
    van den Belt-Dusebout AW, de Wit R, Gietema JA et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.[see comment]. J Clin Oncol 2007; 25: 43704378
  • 32
    Schaapveld M, van den Belt-Dusebout AW, Gietema JA et al. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours. Br J Cancer 2012; 107: 16371643
  • 33
    Cox J. Cost analysis of adjuvant management strategies in early-stage testicular seminoma. Genitourin Cancer Symp Proc 2013
  • 34
    Sridharan S, Chung P, Warde P. The Management of Relapsed Stage I Seminoma. Genitourin Cancer Symp Proc 2013